Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For SYNA
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
33%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q3 Δ in %
Current Ratio 17.50 5.32 4.53
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 50.22 31.39 20.89
Naive Interpretation member
2 Per Share
Metric Q2 Q3 Δ in %
Book Value 0.98 31.44 31.13
Cash -2.62 21.08 21.65
Capex 13.68 -0.23 -0.27
Free Cash Flow -21.38 -0.58 0.73
Revenue -0.13 6.04 6.05
Naive Interpretation member
3 Profitability
Metric Q2 Q3 Δ in %
Gross Margin -2.60 0.45 0.46
Operating Margin 1.80 -0.07 -0.08
ROA -103.77 < 0.005 < 0.005
ROE -98.65 -0.01 < 0.005
ROIC -106.01 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of SYNA is permitted for members.
5 Growth
The "Growth Entry" for the Focus of SYNA is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of SYNA is permitted for members.